Cytodyn Inc.
CYDY
Revenue
225.00k
▲184.00k▲448.78%
3 Months ChangeAssets
28.02M
▲16.89M▲151.63%
3 Months ChangeLiabilities
113.23M
▼-14.66M▼-11.46%
3 Months ChangeFree Cash Flow
-31.75M
▲9.26M▲22.58%
12 Months ChangeRevenue/Cost Of Revenue
Revenue
Cost Of Revenue
Loading...
Date | Revenue | Cost Of Revenue |
---|---|---|
Net Profit/Loss
Net Profit/Loss
Baseline
Loading...
Date | Net Profit/Loss |
---|---|
Assets/Liabilities
Assets
Liabilities
Loading...
Date | Assets | Liabilities |
---|---|---|
Cash Flows
Operating (Cash Flow)
Investing (Cash Flow)
Financing (Cash Flow)
Free Cash Flow
Loading...
Date | Operating (Cash Flow) | Investing (Cash Flow) | Financing (Cash Flow) | Free Cash Flow |
---|---|---|---|---|
EPS
EPS (Diluted)
Loading...
Date | EPS | EPS (Diluted) |
---|---|---|
Outstanding Shares
Loading...
Date | Outstanding Shares |
---|---|
Recent 8-K/10-Q Filings
2024-10-15
Form 10-Q
ID: 0001558370-24-013320
2024-07-09
Form 8-K
ID: 0001558370-24-009701
2024-06-28
Form 8-K
ID: 0001558370-24-009629
2024-06-03
Form 8-K
ID: 0001558370-24-008869
2024-05-06
Form 8-K
ID: 0001558370-24-006814
2024-04-15
Form 10-Q
ID: 0001558370-24-005134
2024-04-08
Form 8-K
ID: 0001558370-24-004802
2024-03-28
Form 8-K
ID: 0001558370-24-004282
2024-01-29
Form 8-K
ID: 0001558370-24-000603
2024-01-16
Form 10-Q
ID: 0001558370-24-000305